Home/Filings/4/0000950170-25-077936
4//SEC Filing

Atomico IV, L.P. 4

Accession 0000950170-25-077936

CIK 0001673743other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 6:38 PM ET

Size

27.2 KB

Accession

0000950170-25-077936

Insider Transaction Report

Form 4
Period: 2025-05-23
Transactions
  • Conversion

    Class B Common Stock

    2025-05-232,651,1036,713,063 total(indirect: See footnotes)
    Class A Common Stock (2,651,103 underlying)
  • Sale

    Class A Common Stock

    2025-05-23$32.00/sh2,651,103$84,835,2960 total(indirect: See footnotes)
  • Other

    Series D Preferred Stock

    2025-05-23510,0730 total(indirect: See footnotes)
    Class B Common Stock (510,073 underlying)
  • Conversion

    Class A Common Stock

    2025-05-23+2,651,1032,651,103 total(indirect: See footnotes)
  • Other

    Series C Preferred Stock

    2025-05-231,175,3330 total(indirect: See footnotes)
    Class B Common Stock (1,175,333 underlying)
  • Other

    Series C-1 Preferred Stock

    2025-05-23602,2980 total(indirect: See footnotes)
    Class B Common Stock (602,298 underlying)
  • Other

    Series A-2 Preferred Stock

    2025-05-234,830,9170 total(indirect: See footnotes)
    Class B Common Stock (4,830,917 underlying)
  • Other

    Series B Preferred Stock

    2025-05-232,245,5450 total(indirect: See footnotes)
    Class B Common Stock (2,245,545 underlying)
  • Other

    Class B Common Stock

    2025-05-23+9,364,1669,364,166 total(indirect: See footnotes)
    Class A Common Stock (9,364,166 underlying)
Transactions
  • Other

    Series A-2 Preferred Stock

    2025-05-234,830,9170 total(indirect: See footnotes)
    Class B Common Stock (4,830,917 underlying)
  • Other

    Class B Common Stock

    2025-05-23+9,364,1669,364,166 total(indirect: See footnotes)
    Class A Common Stock (9,364,166 underlying)
  • Other

    Series B Preferred Stock

    2025-05-232,245,5450 total(indirect: See footnotes)
    Class B Common Stock (2,245,545 underlying)
  • Other

    Series D Preferred Stock

    2025-05-23510,0730 total(indirect: See footnotes)
    Class B Common Stock (510,073 underlying)
  • Conversion

    Class B Common Stock

    2025-05-232,651,1036,713,063 total(indirect: See footnotes)
    Class A Common Stock (2,651,103 underlying)
  • Sale

    Class A Common Stock

    2025-05-23$32.00/sh2,651,103$84,835,2960 total(indirect: See footnotes)
  • Conversion

    Class A Common Stock

    2025-05-23+2,651,1032,651,103 total(indirect: See footnotes)
  • Other

    Series C-1 Preferred Stock

    2025-05-23602,2980 total(indirect: See footnotes)
    Class B Common Stock (602,298 underlying)
  • Other

    Series C Preferred Stock

    2025-05-231,175,3330 total(indirect: See footnotes)
    Class B Common Stock (1,175,333 underlying)
Transactions
  • Sale

    Class A Common Stock

    2025-05-23$32.00/sh2,651,103$84,835,2960 total(indirect: See footnotes)
  • Other

    Series C-1 Preferred Stock

    2025-05-23602,2980 total(indirect: See footnotes)
    Class B Common Stock (602,298 underlying)
  • Other

    Class B Common Stock

    2025-05-23+9,364,1669,364,166 total(indirect: See footnotes)
    Class A Common Stock (9,364,166 underlying)
  • Conversion

    Class A Common Stock

    2025-05-23+2,651,1032,651,103 total(indirect: See footnotes)
  • Other

    Series A-2 Preferred Stock

    2025-05-234,830,9170 total(indirect: See footnotes)
    Class B Common Stock (4,830,917 underlying)
  • Other

    Series B Preferred Stock

    2025-05-232,245,5450 total(indirect: See footnotes)
    Class B Common Stock (2,245,545 underlying)
  • Other

    Series C Preferred Stock

    2025-05-231,175,3330 total(indirect: See footnotes)
    Class B Common Stock (1,175,333 underlying)
  • Other

    Series D Preferred Stock

    2025-05-23510,0730 total(indirect: See footnotes)
    Class B Common Stock (510,073 underlying)
  • Conversion

    Class B Common Stock

    2025-05-232,651,1036,713,063 total(indirect: See footnotes)
    Class A Common Stock (2,651,103 underlying)
Footnotes (3)
  • [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock of the Issuer, except for the Series E Preferred Stock, automatically converted and was reclassified into one share of Class B Common Stock. Each share of Class B Common Stock will be convertible at any time at the option of the holder into one share of Class A Common Stock. The Class B Common Stock will automatically convert into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation.
  • [F2]Atomico Advisors IV, Ltd. is the general partner of Atomico IV L.P. ("Atomico IV") and Atomico IV (Guernsey), L.P. ("Atomico IV (Guernsey)"). As a result, Atomico Advisors IV, Ltd. may be deemed to have beneficial ownership of the shares held by each of Atomico IV and Atomico IV (Guernsey).
  • [F3]Following the transactions reported in this Form 4, the Reporting Persons beneficially own (i) 5,476,823 shares of Class B Common Stock held by Atomico IV and (ii) 1,236,240 shares of Class B Common Stock held by Atomico IV (Guernsey).

Documents

1 file

Issuer

Hinge Health, Inc.

CIK 0001673743

Entity typeother
IncorporatedCayman Islands

Related Parties

1
  • filerCIK 0001652865

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 6:38 PM ET
Size
27.2 KB